Apparatus and methods for assessing metabolic substrate utilization

• US 7,654,955 B2
• Filed: 11/19/2004
• Issued: 02/02/2010
• Est. Priority Date: 11/19/2003
• Status: Expired due to Fees

• Current Assignee: Entelos Holding Corp. (SilkRoad Inc.)
• Original Assignee: Entelos, Inc. (SilkRoad Inc.)
• Inventors: Hall, Kevin, Polidori, David
• Primary Examiner(s): Nasser; Robert L
• Application Number:
  US10/995,030
• Publication Number:
  US 20050197785A1
• Time in Patent Office: 1,901 Days
• Field of Search: None
• US Class Current: 600/300
• CPC Class Codes: G16H 10/20 for electronic clinical trials or questionnaires

Abstract

Apparatus and methods for assessing metabolic substrate utilization are described. In one embodiment, a processor-readable medium includes code to receive data indicative of a plasma glucose concentration, a plasma free fatty acid concentration, and a respiratory quotient of a subject. The processor-readable medium also includes code to calculate, based on the data, respective values of a set of metabolic parameters. The set of metabolic parameters includes a first metabolic parameter and a second metabolic parameter. The value of the first metabolic parameter is indicative of whether the subject has a predisposition towards oxidation of a first type of metabolic substrate or a second type of metabolic substrate, and the value of the second metabolic parameter is indicative of the subject'"'"'s responsiveness to a change in availability of the first type of metabolic substrate or the second type of metabolic substrate.

Claims

1. A processor-readable medium, comprising:

code to receive data indicative of a blood glucose level, a blood free fatty acid level, and a respiratory quotient of a subject; and

code to calculate, based on the data, a value of a metabolic parameter for the subject, the value of the metabolic parameter being indicative of whether the subject has a predisposition towards one of carbohydrate oxidation and fat oxidation.

2. The processor-readable medium of claim 1, wherein the data includes a first set of measurement results and a second set of measurement results, the first set of measurement results being indicative of the blood glucose level, the blood free fatty acid level, and the respiratory quotient of the subject at a first measurement time, the second set of measurement results being indicative of the blood glucose level, the blood free fatty acid level, and the respiratory quotient of the subject at a second measurement time, the first measurement time being different from the second measurement time.

3. The processor-readable medium of claim 1, wherein the code to calculate the value of the metabolic parameter includes code to perform a regression analysis on the data.

4. The processor-readable medium of claim 1, further comprising:

code to compare the value of the metabolic parameter with a baseline value.

5. The processor-readable medium of claim 1, wherein the metabolic parameter is a first metabolic parameter, the processor-readable medium further comprising:

code to calculate, based on the data, a value of a second metabolic parameter for the subject, the value of the second metabolic parameter being indicative of the subject'"'"'s responsiveness to a change in carbohydrate availability.

6. The processor-readable medium of claim 1, wherein the metabolic parameter is a first metabolic parameter, the processor-readable medium further comprising:

code to calculate, based on the data, a value of a second metabolic parameter for the subject, the value of the second metabolic parameter being indicative of the subject'"'"'s responsiveness to a change in fat availability.

7. A computer-implemented method, comprising:

applying a set of measurements to a subject to produce a set of measurement results for the subject, the set of measurements being configured to evaluate a blood glucose level, a blood free fatty acid level, and a respiratory quotient of the subject;

based on the set of measurement results, using a computer to determine whether the subject has a predisposition towards one of carbohydrate oxidation and fat oxidation; and

displaying the determination on a user-interface.

8. The method of claim 7, wherein the set of measurements is configured to measure the blood glucose level, the blood free fatty acid level, and the respiratory quotient of the subject after an overnight fast.

9. The method of claim 7, wherein the set of measurements includes a first set of measurements and a second set of measurements, the first set of measurements being configured to measure the blood glucose level, the blood free fatty acid level, and the respiratory quotient of the subject at a first measurement time, the second set of measurements being configured to measure the blood glucose level, the blood free fatty acid level, and the respiratory quotient of the subject at a second measurement time, the first measurement time being different from the second measurement time.

10. The method of claim 7, wherein the determining whether the subject has the predisposition includes applying a regression analysis on the set of measurement results.

11. The method of claim 7, wherein the determining whether the subject has the predisposition includes:

based on the set of measurement results, calculating a value of a metabolic parameter of the subject, the value of the metabolic parameter being indicative of whether the subject has the predisposition; and

comparing the value of the metabolic parameter with a baseline value.

12. The method of claim 7, further comprising:

based on the set of measurement results, determining the subject'"'"'s responsiveness to a change in carbohydrate availability.

13. The method of claim 7, further comprising:

based on the set of measurement results, determining the subject'"'"'s responsiveness to a change in fat availability.

14. The method of claim 7, further comprising:

based on whether the subject has the predisposition, diagnosing a metabolic disorder of the subject.

15. The method of claim 7, further comprising:

based on whether the subject has the predisposition, selecting a therapy for the subject.

16. The method of claim 7, further comprising:

based on whether the subject has the predisposition, selecting the subject for a clinical trial of a therapy.